STOCK TITAN

Scilex Holding Company (SCLX) notifies SEC of delayed 2025 10-K filing

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
NT 10-K

Rhea-AI Filing Summary

Scilex Holding Company notified the SEC that it cannot file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 by the prescribed due date of March 31, 2026 because it needs additional time to finalize financial statements, including the consolidation of Vivasor Holding Company. The company anticipates filing the Form 10-K on or before April 15, 2026.

Positive

  • None.

Negative

  • None.

Insights

Delay appears procedural; consolidation work is the cited reason.

The notification states the company requires additional time to finalize financial statements tied to the consolidation of Vivasor Holding Company, and seeks the Rule 12b-25 extension to April 15, 2026. This frames the issue as an accounting and reporting timing matter rather than a disclosed restatement.

Key dependencies include timely completion of consolidation entries, internal controls review, and any accounting judgments. Subsequent filings will confirm whether the extension sufficed or further action is required.

Fiscal year end December 31, 2025 Period covered by the delayed Form 10-K
Prescribed due date March 31, 2026 Original Form 10-K filing deadline
Anticipated filing date April 15, 2026 Date company expects to file under Rule 12b-25 extension
Contact Stephen Ma, (650) 516-4310 CFO listed for inquiries
Rule 12b-25 regulatory
"unable to file...and the registrant seeks relief pursuant to Rule 12b-25(b)"
Rule 12b-25 is an SEC filing provision that lets a company notify regulators and the public that it cannot file a required periodic report (like a quarterly or annual report) on time and explains the reason for the delay. For investors, the notice is a formal heads-up that financial information will arrive late—similar to a company calling to say it will be late turning in homework—so it signals increased uncertainty and may affect trading and risk assessments until the filing is available.
consolidation financial
"finalize its financial statements to be included in such Form 10-K, including the consolidation of Vivasor Holding Company"
Consolidation is a period when a stock’s price moves within a relatively narrow range, reflecting a balance between buyers and sellers after a prior rise or fall. It matters to investors because it often signals a pause before the next meaningful move — like a coiled spring — and helps with timing trades, setting risk limits and deciding whether momentum will resume upward or reverse downward.
forward-looking statements regulatory
"This Form 12b-25 includes “forward-looking statements” within the meaning"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 12b-25

NOTIFICATION OF LATE FILING

SEC File Number: 001-39852

CUSIP Number: 80880W106

(Check One): Form 10-K ☐ Form 20-F ☐ Form 11-K

☐Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR

 

For Period Ended: December 31, 2025

☐ Transition Report on Form 10-K

☐ Transition Report on Form 20-F

☐ Transition Report on Form 11-K

☐ Transition Report on Form 10-Q

For the Transition Period Ended:

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

PART I
REGISTRANT INFORMATION

Scilex Holding Company
Full Name of Registrant


Former Name if Applicable

960 San Antonio Road
Address of Principal Executive Office (Street and Number)

Palo Alto, California 94303
City, State and Zip Code

 


PART II
RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

(a) The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

(b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and

(c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III
NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

Scilex Holding Company (the “Company”) has determined that it is unable, without unreasonable effort or expense, to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “Form 10-K”) by March 31, 2026, the prescribed due date, because it requires more time to finalize its financial statements to be included in such Form 10-K, including the consolidation of Vivasor Holding Company. The Company is working diligently to complete the Form 10-K as soon as practicable, which the Company anticipates will not be later than the fifteenth calendar day following the prescribed due date for the Form 10-K, or April 15, 2026.

 

PART IV
OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this notification

Stephen Ma, Chief Financial Officer

(650)

516-4310

(Name)

(Area Code)

(Telephone Number)

 

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s). Yes No

 

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? ☐ Yes ☑ No

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

2

 


 

Forward-Looking Statements

 

This Form 12b-25 includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Statements in this filing about the Company that are not historical facts are forward-looking statements based on the Company’s current expectations, assumptions, estimates and projections. These forward-looking statements are subject to risks and uncertainties that could cause actual future events or results to differ materially from such statements. These forward-looking statements are based on our current expectations, which may not prove to be accurate. The words “believe,” “may,” “will,” “estimate,” “potential,” “continue,” “anticipate,” “intend,” “expect,” “could,” “would,” “project,” “plan,” “target” and similar expressions are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding the Company’s beliefs and expectations relating to the filing of the Form 10-K and the results of the ongoing review. Important factors that may cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, a material delay in the Company’s financial reporting, including the possibility that the Company will not be able to file its Form 10-K within the extension permitted by Rule 12b-25 of the Securities Exchange Act of 1934, as amended, and the possibility that the ongoing review may identify errors or control deficiencies in the Company’s accounting practices. The Company disclaims and does not undertake any obligation to update or revise any forward-looking statement in this report, except as required by applicable law or regulation.

 

3

 


Scilex Holding Company

(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

Date: April 1, 2026

By: /s/ Stephen Ma

 

Stephen Ma

Chief Financial Officer

Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).

4

 


FAQ

Why did Scilex (SCLX) file a Form 12b-25 for its 2025 10-K?

Because it needs more time to finalize financial statements tied to consolidation. The company cites the consolidation of Vivasor Holding Company as the reason and says it is working to complete the Form 10-K.

When does Scilex expect to file the delayed 2025 Form 10-K?

Scilex anticipates filing on or before April 15, 2026. The company invoked Rule 12b-25 and set that date as the fifteenth calendar day after the prescribed March 31, 2026 due date.

Does the Form 12b-25 indicate a material change to 2025 results for SCLX?

The filing does not state a specific material change in results. The form asks whether significant changes are expected and includes no quantitative disclosure in this notification.

Who is the contact at Scilex regarding the late filing?

The contact is Stephen Ma, Chief Financial Officer, at (650) 516-4310. He signed the Form 12b-25 dated April 1, 2026 on the company's behalf.

What does Rule 12b-25 allow companies like Scilex to do?

Rule 12b-25 permits a short extension to file periodic reports when additional time is needed. Scilex used it to state the 10-K will be filed within the 15-calendar-day extension period.